Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Chemistry|December 17, 2010
Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancerJürgen Kratzsch, Anne Petzold, Friedhelm Raue, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 8, 2023
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy menKatharina Lechner, Sarah Heel, Manfred Uhr, et al.
Endocrine|February 4, 2021
Patients' perception on the quality of care for multiple endocrine neoplasia disorders in Europe: an online survey from a patient support groupKarl Philipp Drewitz, Jo Grey, Petra Brügmann, et al.
JCI Insight|January 11, 2019
Effect of mirtazapine on metabolism and energy substrate partitioning in healthy menJohannes M Hennings, Sarah Heel, Katharina Lechner, et al.
Clinical Chemistry|July 9, 2017
United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for CalcitoninGeorge J Kahaly, Alicia Algeciras-Schimnich, Thomas E Davis, et al.
European Journal of Endocrinology|October 31, 2003
Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomasJan-Oliver Thiele, Penny Lohrer, Ludwig Schaaf, et al.
European Journal of Endocrinology|September 27, 2016
Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotypeMarkus Glaudo, Saskia Letz, Marcus Quinkler, et al.
Cancers|July 27, 2022
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry AnalysisViktoria Florentine Koehler, Pia Adam, Carmina Teresa Fuss, et al.
Thyroid : Official Journal of the American Thyroid Association|March 27, 2015
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinomaSamuel A Wells, Sylvia L Asa, Henning Dralle, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Pageof 8